Project Grant HT94252410044
Award Date
2/2/24
Completion Date
1/31/27
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Syracuse, NY 13210, USA
Similar Awards
This $998,436 Project Grant was awarded on July 1, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Research Foundation for the State University of New York (RF SUNY) to study the molecular mechanisms and therapeutic potential of heparan sulfate proteoglycans in remyelination. This 3-year research project aims to transform health care for Service Members and the American public through innovative and...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,179,730 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) at the University at Albany. The grant, under the Military Medical Research and Development program (CFDA 12.420), will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder affecting muscle function. The four-year grant, which began on April 1, 2024, will support basic,...
This Project Grant award valued at $3,255,124.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Research Foundation for the State University of New York (SUNY). The grant funds a multi-year project to develop a "multimodal nanotrap" aimed at alleviating acute respiratory distress syndrome (ARDS) in traumatic injuries. The Research Foundation for SUNY, serving as the sponsored programs administrator for the SUNY...
This federal Project Grant award of $554,875.00 was awarded on March 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Research Foundation for the State University of New York (RF SUNY). The funding will support a 3-year research project titled "TRANSLATION DYSREGULATION IN METASTATIC BREAST CANCER: IMPLICATIONS FOR DISEASE AND IMMUNOTHERAPY OUTCOMES". The objective is to investigate the role of translational...
This federal Project Grant award of $673,448.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award was granted to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,938,711 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) on April 1, 2024. The grant will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder that causes progressive muscle weakness and wasting. The project aims to transform health care for service members and the public by conducting...
The Research Foundation for the State University of New York will receive $476,112 under a two-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program to support research titled "Induction of Oligodendrocyte Progenitor Cell Differentiation by Blocking Store-Operated Oscillatory Calcium Release." The grant aims to advance biomedical research solutions for military and civilian health care through investigating medical...
The Research Foundation for the State University of New York (RF-SUNY) was awarded $768,825 under the Military Medical Research and Development grant program (CFDA 12.420) by the Defense Health Agency to test RNA aptamers in the SOD1 G93A ALS mouse model from September 1, 2023 to August 31, 2025. This funding will support RF-SUNY's research at the University at Albany to investigate medical solutions for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, by exploring the...
Albany Medical College received a $733,500 Project Grant award from the Defense Health Agency dated June 1, 2023 through May 31, 2026 under the Military Medical Research and Development federal grant program (CFDA 12.420). Through this award, Albany Medical College will conduct research investigating medical solutions for the battlefield by harnessing RVE1 to treat bone marrow failure. The Military Medical Research and Development program aims to transform military and public health through...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...